D-1480-2016 Class II Terminated

Recalled by Isomeric Pharmacy Solution, LLC — Salt Lake City, UT

FDA drug recall D-1480-2016 was initiated by Isomeric Pharmacy Solution, LLC on Jun 29, 2016 and is designated Class II. Reason for recall: Lack of Processing Controls: Isomeric Pharmacy Solution, LLC announces a voluntary field action for the Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection because the sterile injectable… The recall status is terminated (terminated Dec 20, 2016). Affected quantity: 274 multdose vials.

Recall details

Product Type
Drugs
Report Date
Sep 14, 2016
Initiation Date
Jun 29, 2016
Termination Date
Dec 20, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
274 multdose vials

Product description

Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection, 10 mL multidose vial, sterile. Rx only. Compounded by Isomeric Pharmacy Solutions, Salt Lake City, UT 84109,

Reason for recall

Lack of Processing Controls: Isomeric Pharmacy Solution, LLC announces a voluntary field action for the Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection because the sterile injectable products were sterilized too long leading to potential difficulty resuspending particles.

Distribution pattern

Nationwide and Puerto Rico. No Canadian, other foreign, govt/VA/military consignees.

Code information

Lots# 03045 and 03046; Exp. 10/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1480-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1480-2016. Report a data issue: hello@regdatalab.com.